IGF2BP1 and thyroid gland carcinoma: Here, we reveal that IGF2BP1 and MAGEA3 are the first reliable protein and RNA markers of ATC, specifically distinguishing this malignancy from any other thyroid cancer of follicular origin, including PDTC.